Guidance overview
This guidance builds on CARE’s ambition—via practice, research, evidence on CVA—and aims to support the application of sensitive CVA throughout the project cycle and at the response level. It is divided into two sections:
- Part A: ‘What has been learned about sensitive CVA?,’ briefly explains the recommendations that came from the research.
- Part B: ‘How do we make CVA sensitive?,’ applies the recommendations to the different phases of the program cycle with suggested indicators to make it easy to put them into practice.
The guidance is designed for CARE and partners who are involved in all stages of programming with CVA—assessment, design, implementation and monitoring, and evaluation—as well as those interacting with other agencies at response and coordination level. It provides prompting questions and topics and meant to complement other resources on CVA and sectors. (See Annex I).